ConductScience.org, home

Paper17516620

A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.

Magnano MD and 6 others. J Rheumatol, 2007. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. Papers, record 17516620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17516620

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.
PubMed
Journal
J Rheumatol
PubMed
Year
2007
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
3.02
iCite
Revised in PubMed
2024-01-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Magnano MDMolly D
2Chakravarty EFEliza F
3Broudy CCorrie
4Chung LLorinda
5Kelman AAriella
6Hillygus JJennifer
7Genovese MCMark C

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antirheumatic AgentsMajor topic
OsteoarthritisMajor topic
Tumor Necrosis Factor-alphaMajor topic
Adalimumab
Aged
Antibodies, Monoclonal, Humanized
Cartilage, Articular
Disability Evaluation
Dose-Response Relationship, Drug
Female
Hand
Humans
Male
Middle Aged
Pilot Projects
Treatment Outcome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
5 M01 RR000070NCRR NIH HHSUnited StatesM01RR000070PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
38157375
Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation.
PLoS One2023https://conductscience.org/library/papers/38157375PubMed
37649531Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.Osteoarthr Cartil Open2023https://conductscience.org/library/papers/37649531PubMed
37492583Effects of synovial macrophages in osteoarthritis.Front Immunol2023https://conductscience.org/library/papers/37492583PubMed
37428931NOS inhibition reverses TLR2-induced chondrocyte dysfunction and attenuates age-related osteoarthritis.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37428931PubMed
36937821An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis.Ther Adv Musculoskelet Dis2023https://conductscience.org/library/papers/36937821PubMed
36507254A new frontier in temporomandibular joint osteoarthritis treatment: Exosome-based therapeutic strategy.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36507254PubMed
35412048[The DRFZ-a pioneer in research on the interaction between immune and stromal cells during de- and regeneration of the musculoskeletal system].Z Rheumatol2022https://conductscience.org/library/papers/35412048PubMed
35105980Erosive hand osteoarthritis: latest findings and outlook.Nat Rev Rheumatol2022https://conductscience.org/library/papers/35105980PubMed
34667642Autologous protein solution: a promising solution for osteoarthritis?EFORT Open Rev2021https://conductscience.org/library/papers/34667642PubMed
34386509Regulation of Tumor Necrosis Factor-α by Peptide Lv in Bone Marrow Macrophages and Synovium.Front Med (Lausanne)2021https://conductscience.org/library/papers/34386509PubMed
32691066A roadmap to target interleukin-6 in osteoarthritis.Rheumatology (Oxford)2020https://conductscience.org/library/papers/32691066PubMed
31621560Innate inflammation and synovial macrophages in osteoarthritis pathophysiology.Clin Exp Rheumatol2019https://conductscience.org/library/papers/31621560PubMed
30983879Exploring the Involvement of NLRP3 and IL-1β in Osteoarthritis of the Hand: Results from a Pilot Study.Mediators Inflamm2019https://conductscience.org/library/papers/30983879PubMed
30552176Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.Ann Rheum Dis2019https://conductscience.org/library/papers/30552176PubMed
29373736Metabolomics of osteoarthritis: emerging novel markers and their potential clinical utility.Rheumatology (Oxford)2018https://conductscience.org/library/papers/29373736PubMed
29123550Mesenchymal Stem Cells for Cartilage Regeneration of TMJ Osteoarthritis.Stem Cells Int2017https://conductscience.org/library/papers/29123550PubMed
27692966Erosive osteoarthritis: A systematic analysis of definitions used in the literature.Semin Arthritis Rheum2017https://conductscience.org/library/papers/27692966PubMed
27539668Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Nat Rev Rheumatol2016https://conductscience.org/library/papers/27539668PubMed
26963090A New Application of Parallel Synthesis Strategy for Discovery of Amide-Linked Small Molecules as Potent Chondroprotective Agents in TNF-α-Stimulated Chondrocytes.PLoS One2016https://conductscience.org/library/papers/26963090PubMed
26713865Genome-Wide DNA Methylation Study Identifies Significant Epigenomic Changes in Osteoarthritic Subchondral Bone and Similarity to Overlying Cartilage.Arthritis Rheumatol2016https://conductscience.org/library/papers/26713865PubMed

See all 51 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17516620

GET https://conductscience.org/api/papers/v1/17516620/cited_by?page=2